SCP Vitalife Partners (Israel) II, L.P., 10% Owner at Recro Pharma, Inc. (REPH), sold 5,896 shares at $7.96 ($47K) on 2017-02-14, disclosed to the SEC on 2017-02-17.
Open-market sale of $47k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.96 | 766 | $6K | 13.1% |
| 2 | $7.96 | 766 | $6K | 13.1% |
| 3 | $7.88 | 2,164 | $17K | 36.6% |
| 4 | $7.86 | 1,100 | $9K | 18.6% |
| 5 | $7.86 | 1,100 | $9K | 18.6% |
| Total | $7.89 avg | 5,896 |
| $47K |
| 100% |
| Filing → |
| REPH | SELL | 2018-01-08 | $14K | — | Filing → |
| REPH | SELL | 2018-01-04 | $230K | — | Filing → |
| REPH | SELL | 2018-01-02 | $56K | — | Filing → |